p53 protein expression and genetic mutation in two primary cell types in pulmonary sclerosing haemangioma

Journal of Clinical Pathology

Volumn 61, Issue 2, 2008, Pages 192-196

  Wang, Y ^b   Dai, S D ^b   Qi, F J ^b   Xu, H T ^b   Wang, En Hua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TUMOR MARKER;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER CAPTURE MICRODISSECTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY SCLEROSING HEMANGIOMA; SINGLE STRAND CONFORMATION POLYMORPHISM; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; METHODOLOGY; MICRODISSECTION; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION;

ADULT; BASE SEQUENCE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICRODISSECTION; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PULMONARY SCLEROSING HEMANGIOMA; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 38849154324     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2007.050401     Document Type: Article

References (24)

1. Devouassoux-Shisheboran M, Hayashi T, Linnoila RI, et al. A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. Am J Surg Pathol 2000;24:906-16.
2. Chan AC, Chan JK. Pulmonary sclerosing hemangioma consistently expresses thyroid transcription facter-1: a new clue to its histogenesis. Arch Pathol Lab Med 2001;125:1531-6.
3. Wang E, Lin D, Wang Y, et al. Immunohistochemical and ultrastructural markers suggest different origins for cuboidal and polygonal cells in pulmonary sclerosing hemangioma. Hum Pathol 2004;35:503- 8.
4. Niho S, Suzuki K, Yokose T, et al. Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung. Am J Pathol 1998;152:1065-9.
5. Dacic S, Sasatomi E, Swalsky PA, et al. Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis. Arch Pathol Lab Med 2004;128:880-4.
6. Miyagawa-Hayashino A, Tazelaar HD, Langel DJ, et al. Pulmonary sclerosing hemangioma with lymph node metastases: report of 4 cases. Arch Pathol Lab Med 2003;127:321-5.
7. Shabnam MS, Srinivasan R, Wali A, et al. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung. Lung Cancer 2004;45:181-8.
8. Miller LD, Smeds J, George J, et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A 2005;102:3550-5.
9. Brambilla E, Negoescu A, Gazzeri S, et al. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors. Am J Pathol 1996;149:1941-52.
10. Jackel MC, Sellmann L, Youssef S, et al. Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx - a multivariate analysis. HNO 2001;49:204-11.
11. Sirvent JJ, Aguilar MC, Olona M, et al. Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study. Histol Histopathol 2004;19:759-70.
12. Bandoh N, Hayashi T, Kishibe K, et al. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma. Cancer 2002;94:1968-80.
13. Chiba W, Sawai S, Yasuda Y, et al. Positive expression of c-myc and p53 products in two cases of pulmonary sclerosing hemangioma. Nihon Kyobu Shikkan Gakkai Zasshi 1995;33:1348-54.
14. Iyoda A, Hiroshima K, Shiba M, et al. Clinicopathological analysis of pulmonary sclerosing hemangioma. Ann Thorac Surg 2004;78:1928-31.
15. Yano M, Yamakawa Y, Kiriyama M, et al. Sclerosing hemangioma with metastases to multiple nodal stations. Ann Thorac Surg 2002;73:981-3.
16. Jungraithmayr W, Eggeling S, Ludwig C, et al. Sclerosing hemangioma of the lung: a benign tumour with potential for malignancy? Ann Thorac Cardiovasc Surg 2006;12:352-4.
17. Chan NG, Melega DE, Inculet RI, et al. Pulmonary sclerosing hemangioma with lymph node metastases. Can Respir J 2003;10:391- 2.
18. Katakura H, Sato M, Tanaka F, et al. Pulmonary sclerosing hemangioma with metastasis to the mediastinal lymph node. Ann Thorac Surg 2005;80:2351-3.
19. Komatsu T, Fukuse T, Wada H, et al. Pulmonary sclerosing hemangioma with pulmonary metastasis. Thorac Cardiovasc Surg 2006;54:348-9.
20. Kim KH, Sul HJ, Kang DY. Sclerosing hemangioma with lymph node metastasis. Yonsei Med J 2003;44:150-4.
21. Tanaka I, Inoue M, Matsui Y, et al. A case of pneumocytoma (so-called sclerosing hemangioma) with lymph node metastasis. Jpn J Clin Oncol 1986;16:77-86.
22. Nagata N, Dairaku M, Sueishi K, et al. Sclerosing hemangioma of the lung. An epithelial tumor composed of immunohistochemically heterogenous cells. Am J Clin Pathol 1987;8:552-9.
23. Dai Shun-Dong, Zhang Xiu-Wei, Qi Feng-Jie, et al. Expression of E-cadherin, β-catenin and p120ctn in the pulmonary sclerosing hemangioma. Lung Cancer 2007;57:54-9.
24. The p53 Web Site. http://p53.free.fr (accessed 10 December 2007).